Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges - Poll - MDSpire

Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges

  • By

  • Ningping Xiao

  • Chao Chen

  • Xiuyu Yang

  • Jiajia Hao

  • Mian Xie

  • Jiangtao Wang

  • Jiayu Xiang

  • Chang Liu

  • Xiulin Jiang

  • Siwei Huang

  • Zijia Wang

  • Yi Jin

  • July 3, 2026

  • 0 min

Share

Original Source(s)

Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges

  • by Ningping Xiao, Chao Chen, Xiuyu Yang, Jiajia Hao, Mian Xie, Jiangtao Wang, Jiayu Xiang, Chang Liu, Xiulin Jiang, Siwei Huang, Zijia Wang, Yi Jin

  • July 3, 2026

Related Content

Does adding immunotherapy to neoadjuvant chemotherapy increase postoperative morbidity in gastroesophageal junction adenocarcinoma? A propensity score-matched study

TREM1 unleashes immunosuppression in glioma: targeting macrophage polarization as a new therapeutic vulnerability

Case report: Secretory carcinoma of the breast with ETV6-NTRK3 fusion: clinicopathological features and molecular confirmation by FISH in two cases